Cargando…

Significance of SARS-CoV-2 specific antibody testing during COVID-19 vaccine allocation

OBJECTIVE: To assess the value of using SARS-CoV-2 specific antibody testing to prioritize the vaccination of susceptible individuals as part of a COVID-19 vaccine distribution plan when vaccine supply is limited. METHODS: An extended susceptible-infected-recovered (SIR) compartmental model was used...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujimoto, Akane B., Keskinocak, Pinar, Yildirim, Inci
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233959/ https://www.ncbi.nlm.nih.gov/pubmed/34274126 http://dx.doi.org/10.1016/j.vaccine.2021.06.067

Ejemplares similares

Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach
por: Kim, Daniel, et al.
Publicado: (2021)

2555. Predicting Risk of Breakthrough Invasive Pneumococcal Disease in Children After 13-Valent Pneumococcal Conjugate Vaccination
por: Yildirim, Melike, et al.
Publicado: (2018)

The balancing role of distribution speed against varying efficacy levels of COVID-19 vaccines under variants
por: Kim, Daniel, et al.
Publicado: (2022)

The Impact of Testing Capacity and Compliance With Isolation on COVID-19: A Mathematical Modeling Study
por: Yu, Zhuoting, et al.
Publicado: (2022)

Value of inventory information in allocating a limited supply of influenza vaccine during a pandemic
por: Li, Zihao, et al.
Publicado: (2018)

Modeling strategies for the allocation of SARS-CoV-2 vaccines in the United States
por: Walker, Joseph, et al.
Publicado: (2022)

Monitoring of SARS-CoV-2 Specific Antibodies after Vaccination
por: Guiomar, Raquel, et al.
Publicado: (2022)

Limited Specificity of Serologic Tests for SARS-CoV-2 Antibody Detection, Benin
por: Yadouleton, Anges, et al.
Publicado: (2021)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies
por: Choy, Kay Weng
Publicado: (2021)

Developing antibody tests for SARS-CoV-2
por: Petherick, Anna
Publicado: (2020)

Profile of specific antibodies to the SARS-CoV-2
por: Mou, Danlei, et al.
Publicado: (2021)

Dynamics and significance of the antibody response to SARS-CoV-2 infection
por: Iyer, Anita S., et al.
Publicado: (2020)

Seroprevalence of anti-SARS-CoV-2 specific antibodies in vaccinated and vaccine naïve adult Nigerians
por: Onifade, Abdulfattah Adekunle, et al.
Publicado: (2023)

Rapid antibody testing for SARS-CoV-2 vaccine response in pediatric healthcare workers
por: Heyming, Theodore W., et al.
Publicado: (2021)

SARS-CoV-2 vaccine-induced antibody and T cell response in SARS-CoV-1 survivors
por: Duan, Li-Jun, et al.
Publicado: (2022)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

Antibodies and Vaccines Target RBD of SARS-CoV-2
por: Min, Long, et al.
Publicado: (2021)

Antibody response to SARS-CoV-2 booster vaccines
por: Loving, Hanna S., et al.
Publicado: (2022)

The Role of Antibody Testing for SARS-CoV-2: Is There One?
por: Theel, Elitza S., et al.
Publicado: (2020)

SARS-CoV-2 antibody testing—questions to be asked
por: Özçürümez, Mustafa K., et al.
Publicado: (2020)

Serological Tests in the Detection of SARS-CoV-2 Antibodies
por: Guevara-Hoyer, Kissy, et al.
Publicado: (2021)

SARS-CoV-2-specific T cells without antibodies
por: Bozkus, Cansu Cimen
Publicado: (2020)

COVID-19 Test Allocation Strategy to Mitigate SARS-CoV-2 Infections across School Districts
por: Pasco, Remy, et al.
Publicado: (2023)

Combination of antibody tests against SARS-CoV-2 for health care workers after vaccination
por: Kittanakom, Saranya, et al.
Publicado: (2022)

Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in Samples from Vaccinated Individuals
por: Hayer, Johannes, et al.
Publicado: (2022)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies – Authors' reply
por: Iversen, Kasper, et al.
Publicado: (2021)

Seven-Month Analysis of Five SARS-CoV-2 Antibody Assay Results after ChAdOx1 nCoV-19 Vaccination: Significant Decrease in SARS-CoV-2 Antibody Titer
por: Jeong, Seri, et al.
Publicado: (2021)

Reflecting on prediction strategies for epidemics: Preparedness and public health response
por: Yildirim, Melike, et al.
Publicado: (2020)

Allocation criteria for an initial shortage of a future SARS-CoV-2 vaccine and necessary measures for global immunity
por: Henn, Wolfram
Publicado: (2020)

Optimal SARS-CoV-2 vaccine allocation using real-time seroprevalence estimates in Rhode Island and Massachusetts
por: Tran, Thu Nguyen-Anh, et al.
Publicado: (2021)

Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants
por: Liu, Feng, et al.
Publicado: (2022)

Age significantly influences the sensitivity of SARS-CoV-2 rapid antibody assays
por: Irwin, Natalie, et al.
Publicado: (2021)

SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
por: Bongiovanni, Marco, et al.
Publicado: (2022)

Screening for SARS-CoV-2 antibodies to save vaccine doses
por: Fenollar, Florence, et al.
Publicado: (2022)

SARS CoV- 2 vaccination induces antibodies against cardiolipin
por: Krashias, George, et al.
Publicado: (2022)

Factors Influencing Antibody Response to SARS-CoV-2 Vaccination
por: Kodde, Cathrin, et al.
Publicado: (2023)

SARS-CoV-2-specific T cells in infection and vaccination
por: Bertoletti, Antonio, et al.
Publicado: (2021)

Diagnostic Properties of Three SARS-CoV-2 Antibody Tests
por: Basgalupp, Suelen, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands
por: Petersen, Maria Skaalum, et al.
Publicado: (2020)

Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies
por: Terry, James S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3904snv9obe1c5iim0r1a56jfl